Improving the radical cure of Plasmodium vivax malaria

American Journal of Tropical Medicine and Hygiene

Volumn 91, Issue 1, 2014, Pages 3-4

  Price, Ric N ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PRIMAQUINE;

EDITORIAL; HEMOLYSIS; MALARIA CONTROL; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRACTICE GUIDELINE; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; CHLOROQUINE; FEMALE; HUMANS; MALARIA, VIVAX; MALE; PRIMAQUINE;

EID: 84903886656     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0118     Document Type: Editorial

References (12)

1. White NJ, 2011. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J 10: 297.
2. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, 2007. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 79-87.
3. Quispe AM, Pozo E, Guerrero E, Durand S, Baldeviano GC, Edgel KA, Graf PCF, Lescano AG, 2014. Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg 91: 11-17.
4. Baird JK, 2014. Editorial: pernicious and threatening Plasmodium vivax as reality. Am J Trop Med Hyg 91: 1-2.
5. Baird JK, Hoffman SL, 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 1336-1345. (Pubitemid 39458520)
6. John GK, Douglas NM, von Seidlein L, Nosten F, Baird JK, White NJ, Price RN, 2012. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J 11: 280.
7. Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S, 2008. High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Am J Trop Med Hyg 78: 736-740. (Pubitemid 351845129)
8. Durand S, Cabezas C, Lescano AG, Galvez M, Gutierrez S, Arrospide N, Alvarez C, Santolalla ML, Bacon DJ, Graf PCF, 2014. Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru. Am J Trop Med Hyg 91: 18-26.
9. Orjuela-Sanchez P, da Silva NS, da Silva-Nunes M, Ferreira MU, 2009. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Am J Trop Med Hyg 81: 961-968.
10. World Health Organisation, 2010. Guidelines for the Treatment of Malaria. Geneva: World Health Organization.
11. Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Mohrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L, 2013. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet, doi: 10.1016/S0140-6736(13)62568-4.
12. Douglas NM, Lampah DA, Kenangalem E, Simpson JA, Poespoprodjo JR, Sugiarto P, Anstey NM, Price RN, 2013. Major burden of severe anemia from non-falciparum malaria species in southern Papua: a hospital-based surveillance study. PLoS Med 10: e1001575.